Monster earnings analysis: questions answered and next catalysts

Monster Beverage Corp (MNST) is trading at $46.55 (-2.68%) as of Nov 6, 12:50 PM EST. Its market cap is about $90.6B. The Q3 print (Nov 5) beat on sales and matched on EPS, but the market focused on costs. The stock also fell on a day when the S&P 500 and Nasdaq were up, so the move is company-specific (Nov 6, 2026).

Monster Beverage Corp (MNST): Q3 revenue $2.56B vs $2.49B est (+16.7% y/y) || EPS $0.30 vs $0.30 est (in line) || Gross margin 54.7% vs 55.7% a year ago || Operating margin 28.0% vs 30.7%

Revenue won, margins blinked

Questions answered

• Is demand still strong? Yes. Sales rose 16.7% to a record. Monster Energy Drinks grew 17.1% to $2.37B, and Strategic Brands grew 19.8%. Alcohol fell 13.6% (Nov 5, 2026).
• Can international keep growing? Yes. International sales rose 28.1% to $1.20B, or 47% of the total, up from 43%. LATAM rose 48.8%, led by Brazil.
• Is Q4 starting well? Yes. October sales rose 11% despite one fewer selling day (Nov 6, 2026).
• Is price increasing a lever? Yes. U.S. price increases took effect Nov 1.
• Is capital return continuing? Yes. Monster bought back about $100M of shares in the quarter and has roughly $800M of authorization left.

Questions left open

• Margin pressure: Aluminum can and freight costs are rising. Management expects the aluminum headwind to last through at least Q1 2027.
• Mix drag: International sales carry structurally lower margins. The growth the market wants is also the source of the margin squeeze.
• Unclear U.S. share: UBS (Neutral, $50 target) said U.S. trends missed expectations and share looks to be deteriorating after improving for most of 2026 (Nov 6, 2026).
• One-offs: The quarter included a $19.9M property impairment and $14.7M of digital transformation costs.
• Valuation: UBS cited a P/E of 44.4. InvestingPro flags the stock as overvalued against its Fair Value. The shares had run up near the $50.17 52-week high before the print.

The reaction pattern

The earnings history shows a stock that has not simply followed beats.

The Q1 rally came with a large beat. Since then the reactions have been negative even with revenue beats, so the market now seems to want margin proof.

Next catalysts

• Q4 and FY26 results: The tentative date is Mar 4, 2027. Consensus is EPS $0.28 and revenue $2.38B. Watch gross margin and any 2027 cost commentary.
• Aluminum and pricing: Whether the Nov 1 price increases offset can costs will show up in the Q4 gross margin.
• 2027 innovation pipeline: Management flagged new products under Monster, Reign, FLRT and protein lines.
• Estimate revisions: EPS estimates slipped 0.80% over 30 days. FY26 consensus is EPS $1.16 and revenue $9.76B. FY27 is $1.31 and $10.70B.
• Analyst stance: Jefferies (Buy, $55 target) and Wells Fargo (Overweight, $52) are constructive. UBS is more cautious.

Bull vs bear

Bull: Double-digit growth, rising international sales and pricing power could rebuild margins once input costs ease.

Bear: A premium multiple leaves little room if aluminum costs persist and U.S. share slips.

Price figures are as of Nov 6, 12:50 PM EST. Consensus and earnings figures are from the latest tool data.